“Ultra high” Potency Development and Manufacture

Case study
Drug substance
Highly potent APIs

A US-based biotechnology company approached Cambrex to develop a process for producing a highly potent API, a DNA alkylator, used to treat an unmet oncology need. The biotechnology company had limited experience in the development and manufacturing of high potency compounds and sought a reliable partner for the pre-clinical development and clinical trial material manufacturing, which could possibly advance to commercial manufacturing, if approved.

To learn why Cambrex’s decades of high potency API experience and collaborative approach led to a successful partnership, read the full case study.